A detailed history of Gamma Investing LLC transactions in Viatris Inc stock. As of the latest transaction made, Gamma Investing LLC holds 21,954 shares of VTRS stock, worth $256,203. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,954
Previous 18,237 20.38%
Holding current value
$256,203
Previous $212 Million 29.09%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$11.32 - $13.37 $42,076 - $49,696
3,717 Added 20.38%
21,954 $273 Million
Q3 2024

Oct 04, 2024

BUY
$10.32 - $12.13 $57,007 - $67,006
5,524 Added 43.45%
18,237 $212 Million
Q2 2024

Jul 02, 2024

BUY
$10.05 - $12.02 $16,853 - $20,157
1,677 Added 15.2%
12,713 $135 Million
Q1 2024

Apr 05, 2024

BUY
$11.27 - $13.53 $18,933 - $22,730
1,680 Added 17.96%
11,036 $132 Million
Q4 2023

Feb 01, 2024

BUY
$8.77 - $10.85 $82,052 - $101,512
9,356 New
9,356 $110 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.